C85.10 is a billable ICD-10 code used to specify a medical diagnosis of unspecified b-cell lymphoma, unspecified site. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
Unspecified diagnosis codes like C85.10 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- ALK-positive large B-cell lymphoma
- B-cell lymphoma
- B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma
- Chronic cold agglutinin disease
- Chronic cold agglutinin disease associated with B-cell neoplasm
- Cold autoimmune hemolytic anemia
- High grade B-cell lymphoma
- High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
- Intermediate grade B-cell lymphoma
- Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease
- Low grade B-cell lymphoma
- Plasmablastic lymphoma
- Primary cutaneous B-cell lymphoma
- Secondary autoimmune hemolytic anemia
- Secondary autoimmune hemolytic anemia co-occurrent and due to lymphoproliferative disorder
- T-cell histiocyte rich large B-cell lymphoma
- Plasmablastic Lymphoma-. malignant lymphoma composed of large b lymphoid cells which have the immunophenotype of plasma cells and a predilection for the oral cavity.
Convert to ICD-9 Code
|Source ICD-10 Code||Target ICD-9 Code|
|C85.10||202.80 - Oth lymp unsp xtrndl org|
|Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.|
Lymphoma is a cancer of a part of the immune system called the lymph system. There are many types of lymphoma. One type is Hodgkin disease. The rest are called non-Hodgkin lymphomas.
Non-Hodgkin lymphomas begin when a type of white blood cell, called a T cell or B cell, becomes abnormal. The cell divides again and again, making more and more abnormal cells. These abnormal cells can spread to almost any other part of the body. Most of the time, doctors don't know why a person gets non-Hodgkin lymphoma. You are at increased risk if you have a weakened immune system or have certain types of infections.
Non-Hodgkin lymphoma can cause many symptoms, such as :
- Swollen, painless lymph nodes in the neck, armpits or groin
- Unexplained weight loss
- Soaking night sweats
- Coughing, trouble breathing or chest pain
- Weakness and tiredness that don't go away
- Pain, swelling or a feeling of fullness in the abdomen
Your doctor will diagnose lymphoma with a physical exam, blood tests, a chest x-ray, and a biopsy. Treatments include chemotherapy, radiation therapy, targeted therapy, biological therapy, or therapy to remove proteins from the blood. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells. Biologic therapy boosts your body's own ability to fight cancer. If you don't have symptoms, you may not need treatment right away. This is called watchful waiting.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)